1
Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Disease(NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran,
2
Alfred Nuclear Medicine, Melbourne , Monash University, Australia
Yousefi-Koma,A. Y. , Panah-Moghaddam,M. and Kalff,V. (1999). The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging. (e241037). TANAFFOS (Respiration), 12(1), e241037
MLA
Yousefi-Koma,A. Y. , , Panah-Moghaddam,M. , and Kalff,V. . "The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging" .e241037 , TANAFFOS (Respiration), 12, 1, 1999, e241037.
HARVARD
Yousefi-Koma A. Y., Panah-Moghaddam M., Kalff V. (1999). 'The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging', TANAFFOS (Respiration), 12(1), e241037.
CHICAGO
A. Y. Yousefi-Koma, M. Panah-Moghaddam and V. Kalff, "The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging," TANAFFOS (Respiration), 12 1 (1999): e241037,
VANCOUVER
Yousefi-Koma A. Y., Panah-Moghaddam M., Kalff V. The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging. TANAFFOS (Respiration), 1999; 12(1): e241037.
